Hospital Mater Dei SA

Hospital Mater Dei SA

6.30
BRL
+0.06
(+0.96%)
0.43EPS
11.34P/E
1.60BMarket Cap
Nov 09Next Earn
Hospital Mater Dei SA
B3:MATD3
(B3)

Recent

price

6.30

P/E

ratio

11.34

div

yld

1.89%

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
BRL
- -
1.77
2.07
2.02
3.37
4.62
5.73
6.52
6.55
6.98
Revenue per Share
- -
0.35
0.39
0.2
0.48
0.27
0.31
-0.99
0.33
0.43
Basic EPS, GAAP
- -
0.05
0.01
0.16
0.1
-0.31
-0.03
-0.2
0.49
0.51
Free Cash Flow per Basic Share
- -
0.06
0.14
0.09
0.09
0.15
0.06
0.08
0.2
0.12
Dividend per Share
1.82
2.09
2.39
0.74
4.29
4.23
4.33
4.24
4.41
4.51
Book Value per Share
1.81
2.07
2.37
0.73
1.21
-0.59
-0.52
2.1
2.21
2.31
Tangible Book Value per Share
355
355
355
355
304
382
382
341
332
332
Basic Weighted Avg Shares
- -
627
733
718
1,024
1,763
2,188
2,226
2,175
2,319
Sales/Revenue/Turnover
- -
30.85
29.21
19.33
26.62
20.22
18.35
15.4
16.26
17.17
Operating Margin (%)
- -
36
47
38
41
90
102
109
111
115
Depreciation Expense
- -
124
138
73
145
104
120
-338
111
142
Net Income, GAAP
- -
34.65
34.58
29.31
33.4
33.98
32.35
- -
33.02
33.26
Effective Tax Rate (%)
- -
19.86
18.85
10.12
14.15
5.87
5.47
-15.2
5.08
6.12
Profit Margin (%)
250
284
338
128
1,403
717
773
1,010
1,003
1,017
Working Capital
104
147
160
361
1,562
1,851
1,965
2,022
1,989
1,975
LT Debt
647
741
847
261
1,683
1,703
1,754
1,476
1,478
1,507
Total Equity
- -
13.5
13.37
8.02
7.41
6.44
7.93
- -
6.4
7.17
Return on Invested Capital (%)
- -
15.38
15.37
8.64
9.19
6.59
6.98
- -
7.97
8.81
Return on Capital (%)
- -
17.93
17.39
13.11
15.25
6.36
7.31
-21.81
7.59
9.63
Return on Common Equity (%)

Capital Structure

BRL

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
191
173
193
LT Borrowings
1,290
1,273
1,254
LT Finance Leases
698
716
722
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
332
332
331
Market Capitalization
1,747
1,902
1,602

Working Capital

BRL

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,494
1,515
1,561
Cash, Cash Equivalents & STI
625
584
628
Accounts Receivable, Net
888
974
973
Inventories
72
79
75
Total Current Liabilities
491
521
544
Payables & Accruals
- -
- -
- -
ST Debt
191
173
193
Deferred Revenue
- -
- -
- -

Growth Rates

BRL

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
106.63%
0.08%
Free Cash Flow
- -
-90.8%
-340.23%
Net Income, GAAP
- -
-85.8%
-132.65%
Sales/Revenue/Turnover
- -
27.67%
-2.28%
Total Cash Common Dividend
- -
38.33%
127.93%

Quarterly Revenue

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
583
585
571
487
2,226
2025
499
546
568
562
2,175
2026
575
614
- -
- -
- -

Quarterly Earnings Per Share

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.11
-1.22
0.2
0.02
-0.99
2025
0.06
0.08
0.08
0.11
0.33
2026
0.1
0.13
- -
- -
- -

Quarterly Dividends Per Share

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.08
2025
- -
- -
- -
0.12
0.2
2026
- -
- -
- -
- -
- -
Business
Hospital Mater Dei S.A. operates as an integrated private healthcare network providing comprehensive inpatient, outpatient, surgical, and diagnostic medical care in Brazil. Founded in 1980 and headquartered in Belo Horizonte, Minas Gerais, the company serves individual private patients, corporate clients, and health insurance beneficiaries through a multi-regional hub-and-spoke hospital infrastructure. The company provides a wide array of specialized healthcare services organized across primary clinical divisions, comprising: inpatient and emergency care services, including adult, pediatric, and neonatal intensive care units (ICU), 24/7 urgent care, observation units, and day-hospital facilities; specialized centers of excellence and high-complexity surgery, encompassing robotic-assisted surgery, cardiovascular interventions, hemodynamics, neurosurgery, orthopedics, traumatology, bone marrow transplantation, bariatric procedures, and comprehensive maternity, obstetric, and neonatal care; integrated cancer care through Mater Dei Oncologia, offering clinical oncology, radiation oncology, chemotherapy infusion, surgical oncology, and specialized patient navigation; comprehensive diagnostic and clinical laboratory testing, featuring magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET-CT), digital mammography, ultrasound, endoscopy, clinical pathology, molecular diagnostics, and genetic testing; outpatient medical consultations across numerous specialties, including cardiology, neurology, gastroenterology, endocrinology, dermatology, and pediatrics; and preventive, post-acute, and digital health services, encompassing executive check-up programs, telemedicine consultations, occupational health management, physical therapy, and multidisciplinary rehabilitation. Geographically, Mater Dei manages healthcare facilities across several major Brazilian regions, with key operations situated in the State of Minas Gerais (including Mater Dei Santo Agostinho, Mater Dei Contorno, Mater Dei Betim-Contagem, and Hospital Santa Clara), Bahia (Mater Dei Salvador and Hospital EMEC), Pará (Hospital Porto Dias), and Goiás. In recent developments, Hospital Mater Dei S.A. has focused on expanding and consolidating its regional footprint following its expansion into strategic metropolitan markets outside Minas Gerais. Key initiatives include the operational ramp-up and service line maturation of Mater Dei Salvador, alongside the operational integration and modernization of acquired regional hospital assets such as Hospital Porto Dias in Belém and Hospital EMEC in Feira de Santana. The company has also expanded its high-margin robotic surgery platforms and specialized oncology network across its regional hubs, entered into enhanced commercial and value-based healthcare partnerships with private health maintenance organizations (HMOs) and insurers, and deployed advanced hospital management systems, centralized electronic medical records, and digital telehealth platforms to optimize operational capacity and clinical outcomes.